Article Details

Bioasis Technologies announces publication validating its xB3 platform to cross the intact blood ...

Retrieved on: 2021-06-03 20:39:56

Tags for this article:

Click the tags to see associated articles and topics

Bioasis Technologies announces publication validating its xB3 platform to cross the intact blood .... View article details on hiswai:

Excerpt

Data published in the Frontiers in Neuroscience provides evidence for the utility of xB3 peptide (previously known as MTfpep) as a platform technology ...

Article found on: www.proactiveinvestors.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up